Navigation auf uzh.ch

Suche

Epidemiology, Biostatistics and Prevention Institute

Natural history of lung cancer in Switzerland and cost-effectiveness of low-dose computed tomography

International studies suggest that early lung cancer screening with low-dose computed tomography for patients at high risk may reduce lung cancer-specific mortality, and may be cost-effective. The aim of the study is to model the natural history of lung cancer as well as the cost and benefits of lung cancer screening programmes in Switzerland. The impact of different eligibility criteria and programme characteristics is also assessed.

 

Output

  • Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study
    Tomonaga Y, Ten Haaf K, Frauenfelder T, Kohler M, Kouyos RD, Shilaih M, Lorez M, de Koning HJ, Schwenkglenks M, Puhan MA.
    Lung Cancer. 2018 Jul;121:61-69. doi: 10.1016/j.lungcan.2018.05.008. Epub ahead of print; PMID: 29858029]

Weiterführende Informationen

Group Leader

Milo Puhan (Group Leader)

Matthias Schwenkglenks (Group Leader)

Yuki Tomonaga

Funding

- Lungenliga Schweiz

- NICER